GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Med Life SA (BSE:M) » Definitions » Research & Development

Med Life (BSE:M) Research & Development : lei0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Med Life Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Med Life's Research & Development for the three months ended in Dec. 2024 was lei0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was lei0 Mil.

Med Life Research & Development Historical Data

The historical data trend for Med Life's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Med Life Research & Development Chart

Med Life Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Med Life Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Med Life Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life  (BSE:M) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Med Life Research & Development Related Terms

Thank you for viewing the detailed overview of Med Life's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Med Life Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Med Life SA (BSE:M) » Definitions » Research & Development
Comparable Companies
BSE:RPH HCA SAU:4013 XTER:FRE SZSE:300015 XTER:FME XKLS:5225 THC BOM:543220 UHS DVA NSE:APOLLOHOSP BSP:RDOR3 BKK:BDMS EHC CHE ADX:PUREHEALTH ENSG BOM:532843 OPCH
Traded in Other Exchanges
N/A
Address
Calea Grivitei, No. 365, District 1, Bucharest, ROU
Website
https://www.medlife.ro
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.